Free accessResearch articleFirst published online 2011-6
Vascular Endothelial Growth Factor (VEGF) and the VEGF Soluble Receptor-1 (sFlt-1) in Chorionic Villus Tissue from Chinese Women with Early Recurrent Spontaneous Abortion
This case—control study explored the relationship between early recurrent spontaneous abortion (RSA) and the expression of two genes: VEGFA, the gene encoding vascular endothelial growth factor (VEGF); and fms-related tyrosine kinase 1 (FLT1), the gene encoding the soluble VEGF receptor-1 (sFlt-1). Women experiencing RSA or undergoing induced abortions in the early stage of normal pregnancy were recruited to the study (n = 30 per group). There were no significant between-group differences in maternal age or duration of pregnancy. The levels of VEGF and sFlt-1 mRNA in chorionic villus tissue samples were examined by quantitative reverse transcription—polymerase chain reaction. Levels of sFlt-1 and VEGF mRNA in the chorionic villus tissue of women with RSA were significantly higher than levels in the control group. This study demonstrated that there is a relationship between early RSA and VEGF and sFlt-1 levels, suggesting that overexpression of the FLT1 and VEGFA genes may be associated with the pathogenesis of RSA.
BhattacharyaSM: Hypo-osmotic swelling test and unexplained repeat early pregnancy loss. J Obstet Gynaecol Res2010; 36: 119–122.
2.
BeeverCLStephensonMDPeñaherreraMS: Skewed X-chromosome inactivation is associated with trisomy in women ascertained on the basis of recurrent spontaneous abortion or chromosomally abnormal pregnancies. Am J Hum Genet2003; 72: 399–407.
NielsenHSSteffensenRLundM: Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage. Hum Reprod2010; 25: 1543–1552.
6.
VonnahmeKAWilsonMEFordSP: Relationship between placental vascular endothelial growth factor expression and placental/endometrial vascularity in the pig. Biol Reprod2001; 64: 1821–1825.
7.
BahtiyarMOBuhimschiCRavishankarV: Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction. Am J Obstet Gynecol2007; 196: 72.e1–72.e6.
8.
FerraraNGerberHPLeCouterJ: The biology of VEGF and its receptors. Nat Med2003; 9: 669–676.
9.
CoultasLChawengsaksophakKRossantJ: Endothelial cells and VEGF in vascular development. Nature2005; 438: 937–945.
10.
JelkmannW: Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem2001; 47: 617–623.
11.
SugimotoHHamanoYCharytanD: Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem2003; 278: 12605–12608.
12.
BanksREForbesMASearlesJ: Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod1998; 4: 377–386.
13.
KappasNCZengGChappellJC: The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J Cell Biol2008; 181: 847–858.
14.
NessRBSibaiBM: Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol2006; 195: 40–49.
15.
ArroyoJAWinnVD: Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol2008; 32: 172–177.
16.
WangYDanH-JFanJ-H: Evaluation of the correlation between colour power Doppler flow imaging and vascular endothelial growth factor in breast cancer. J Int Med Res2010; 38: 1077–1083.
17.
OnoueKUemuraSTakedaY: Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction. Am J Cardiol2009; 104: 1478–1483.
18.
CarmelietPFerreiraVBreierG: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature1996; 380: 435–439.
19.
ShiraishiSNakagawaKKinukawaN: Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta1996; 17: 111–121.
20.
BrockelsbyJCAnthonyFWJohnsonIR: The effects of vascular endothelial growth factor on endothelial cells: A potential role in preeclampsia. Am J Obstet Gynecol2000; 182: 176–183.
21.
ZygmuntMHerrFMünstedtK: Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol2003; 110 (suppl 1): S10–S18.
22.
KrüsselJSBehrBHirchenhainJ: Expression of vascular endothelial growth factor mRNA in human preimplantation embryos derived from tripronuclear zygotes. Fertil Steril2000; 74: 1220–1226.
23.
MaynardSEMinJYMerchanJ: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest2003; 111: 649–658.
24.
BridgesJPGilbertJSColsonD: Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens2009; 22: 564–568.
25.
VuorelaPCarpénOTulppalaM: VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod2000; 6: 276–282.
26.
BurtonGJCharnock-JonesDSJauniauxE: Regulation of vascular growth and function in the human placenta. Reproduction2009; 138: 895–902.
27.
González-PachecoFRDeuderoJJCastellanosMC: Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H2O2. Am J Physiol Heart Circ Physiol2006; 291: H1395–H1401.
28.
RodeschFSimonPDonnerC: Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol1992; 80: 283–285.
29.
McKeemanGCArdillJECaldwellCM: Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol2004; 191: 1240–1246.
30.
MakrisAThorntonCThompsonJ: Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int2007; 71: 977–984.
31.
NevoOSoleymanlouNWuY: Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol2006; 291: R1085–R1093.
32.
MutterWPKarumanchiSA: Molecular mechanisms of preeclampsia. Microvasc Res2008; 75: 1–8.
